Aimo Kannt

18PUBLICATIONS
97CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsBiocatalysis and enzyme technologyGroundwater quality processes and contaminated land assessmentBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 27, 2026
CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial.

|Apr 11, 2026
Glycan-based biological degraders targeting the cytokine immune axis.

Michelle Seifert, Tim Kollenkirchen, Andreas Ernst

|Oct 21, 2025
Click chemistry enables rapid development of potent sEH PROTACs using a direct-to-biology approach.

Julia Schönfeld, Nick Liebisch, Steffen Brunst

|Aug 26, 2025
Wastewater as an early indicator for short-term forecasting COVID-19 hospitalization in Germany.

Jonas Radermacher, Steffen Thiel, Aimo Kannt

|Aug 14, 2025
Optimization and Evaluation of Complementary Degrader Discovery Assays for Application in Screening.

Johanna Huchting, Arjen Weller, Moyra Schweizer

|Jun 18, 2025
Structure-Based Design of PROTACS for the Degradation of Soluble Epoxide Hydrolase.

Julia Schönfeld, Steffen Brunst, Ludmila Ciomirtan

Pageof 3

Frequent Collaborators

2 joint publications

Kerstin Hiesinger

2 joint publications

Stefan Knapp

2 joint publications

Jan Heering

1 joint publications

Gerhard Krönke